Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-06

FDA Approved: CLOFARABINE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves a generic version of CLOFARABINE (Amneal) under an Original Application for the treatment of acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clofarabine (clofarabine)

Snippet

ORIG AP for CLOFARABINE (CLOFARABINE)